IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $627,038,000 | +32.7% | 7,725,000 | -11.6% | 15.76% | +4.1% |
| Q4 2018 | $472,557,000 | +5.7% | 8,741,334 | +0.9% | 15.14% | +28.0% |
| Q3 2018 | $447,010,000 | +23.8% | 8,666,334 | 0.0% | 11.83% | +13.4% |
| Q2 2018 | $361,126,000 | -3.8% | 8,666,334 | +1.8% | 10.43% | +0.5% |
| Q1 2018 | $375,400,000 | -8.3% | 8,516,334 | +4.7% | 10.38% | -10.0% |
| Q4 2017 | $409,258,000 | +2.7% | 8,136,334 | +3.5% | 11.52% | +4.4% |
| Q3 2017 | $398,600,000 | +6.5% | 7,861,934 | +6.9% | 11.03% | -3.5% |
| Q2 2017 | $374,103,000 | +24.7% | 7,354,095 | -1.4% | 11.44% | +16.6% |
| Q1 2017 | $299,944,000 | -9.3% | 7,461,295 | +7.9% | 9.81% | -19.9% |
| Q4 2016 | $330,657,000 | +26.0% | 6,913,172 | -3.5% | 12.25% | +32.7% |
| Q3 2016 | $262,459,000 | +58.6% | 7,163,172 | +0.8% | 9.23% | +41.2% |
| Q2 2016 | $165,472,000 | -39.7% | 7,104,838 | +4.8% | 6.53% | -40.1% |
| Q1 2016 | $274,583,000 | -32.1% | 6,779,838 | +3.8% | 10.91% | -4.2% |
| Q4 2015 | $404,393,000 | – | 6,529,838 | – | 11.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |